North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
- PMID: 25919383
- PMCID: PMC4417745
- DOI: 10.1097/NMD.0000000000000290
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
Abstract
In studies describing the long-term follow-up up of youth at clinical high risk (CHR) of psychosis, little attention has been given to details of specific prodromal symptoms. In this paper, we describe the prodromal symptoms of 764 CHR participants recruited in the multi-site North American Prodrome Longitudinal Study (NAPLS). Symptoms were rated on the Scale of Prodromal Symptoms (SOPS) at baseline and 6-, 12-, 18-, and 24-month follow-ups. Clinical outcome at the 2-year assessment was categorized as psychotic, prodromal progression, symptomatic or in remission. Most of the CHR sample (92%) met criteria for the attenuated positive symptoms syndrome (APSS). Significant improvements in SOPS symptoms were observed over time. Unusual thought content, disorganized communication, and overall ratings on disorganized symptoms differentiated those who transitioned to psychosis from the other clinical outcome groups. Suspiciousness and total positive symptoms differentiated those in remission from the other clinical outcome groups.
References
-
- Addington J, Heinssen R. Prediction and Prevention of Psychosis in Youth at Clinical High Risk. Annu Rev Clin Psychol. 2011 - PubMed
-
- Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Interv Psychiatry. 2014 - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- K24 MH76191/MH/NIMH NIH HHS/United States
- U01 MH082022/MH/NIMH NIH HHS/United States
- U01 MH081984/MH/NIMH NIH HHS/United States
- R01 MH60720/MH/NIMH NIH HHS/United States
- U01MH082004/MH/NIMH NIH HHS/United States
- P50MH066286/MH/NIMH NIH HHS/United States
- U01 MH081902/MH/NIMH NIH HHS/United States
- P50 MH080272/MH/NIMH NIH HHS/United States
- U01MH082022/MH/NIMH NIH HHS/United States
- U01 MH081988/MH/NIMH NIH HHS/United States
- UO1MH081857-05/MH/NIMH NIH HHS/United States
- P50 MH066286/MH/NIMH NIH HHS/United States
- U01MH081988/MH/NIMH NIH HHS/United States
- U01 MH076989/MH/NIMH NIH HHS/United States
- K24 MH076191/MH/NIMH NIH HHS/United States
- U01MH081902/MH/NIMH NIH HHS/United States
- U01MH081984/MH/NIMH NIH HHS/United States
- R01 MH060720/MH/NIMH NIH HHS/United States
- U01 MH081928/MH/NIMH NIH HHS/United States
- U01 MH081857/MH/NIMH NIH HHS/United States
- U01 MH082004/MH/NIMH NIH HHS/United States
- U01 MH081944/MH/NIMH NIH HHS/United States